Paradigm Financial Advisors’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q1
Sell
-4,947
Closed -$354K 125
2017
Q4
$354K Sell
4,947
-3,798
-43% -$288K 0.16% 81
2017
Q3
$708K Buy
8,745
+22
+0.3% +$1.68K 0.34% 52
2017
Q2
$617K Buy
8,723
+26
+0.3% +$1.73K 0.31% 55
2017
Q1
$590K Sell
8,697
-30,478
-78% -$2.14M 0.3% 55
2016
Q4
$2.81M Sell
39,175
-2,976
-7% -$221K 1.53% 21
2016
Q3
$3.33M Sell
42,151
-16,473
-28% -$1.34M 2% 18
2016
Q2
$4.89M Buy
58,624
+3,396
+6% +$301K 2.96% 12
2016
Q1
$5.07M Buy
55,228
+642
+1% +$57.9K 1.97% 9
2015
Q4
$5.52M Buy
54,586
+1,388
+3% +$144K 3.47% 4
2015
Q3
$5.22M Buy
53,198
+16,020
+43% +$1.78M 3.44% 4
2015
Q2
$4.35M Buy
37,178
+2,650
+8% +$290K 3.27% 8
2015
Q1
$3.39M Buy
34,528
+4,593
+15% +$466K 2.62% 15
2014
Q4
$2.82M Buy
29,935
+8,225
+38% +$851K 2.29% 20
2014
Q3
$2.31M Buy
+21,710
New +$2.13M 1.97% 23

Other funds holding GILD

Paradigm Financial Advisors's GILD Position: Q1 2018 in Review

Paradigm Financial Advisors sold out of Gilead Sciences (GILD) in Q1 2018, closing a stake of 4,947 shares — an estimated $354K sold.

Paradigm Financial Advisors first reported a position in GILD in Q3 2014 and held it in 14 quarters. The position peaked at $5.52M in Q4 2015. 1,563 funds tracked by Wall St. Rank hold GILD as of Q1 2018.

  • Paradigm Financial Advisors reported no remaining Gilead Sciences position as of Q1 2018 after selling out during the quarter.
  • Paradigm Financial Advisors sold 4,947 Gilead Sciences shares in Q1 2018, an estimated $354K.
  • Paradigm Financial Advisors first reported a position in Gilead Sciences in Q3 2014 and held it in 14 quarters.
  • Paradigm Financial Advisors's Gilead Sciences position peaked at $5.52M in Q4 2015.
  • 1,563 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2018.

Based on Paradigm Financial Advisors's 13F filing for Q1 2018, filed 2 May 2018.